Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hopf

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction]R Zimmermann, V König, J Bauditz, et al.
Journal of Hepatology|October 9, 1998
A clinical and virological study of hepatitis C virus-related cryoglobulinemia in GermanyS M Weiner, T Berg, H Berthold, et al.
Journal of Medical Virology|August 10, 1999
Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donorsT Berg, E Schreier, H G Heuft, et al.
Transplantation Proceedings|September 2, 1998
Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantationK P Platz, A R Mueller, C Willimski, et al.
Transplantation|September 15, 1994
Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantationV König, U Hopf, P Neuhaus, et al.
Transplantation Proceedings|June 24, 1998
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantationK P Platz, A R Mueller, C Willimski, et al.
Hepatology (Baltimore, Md.)|January 13, 1998
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantationU Protzer-Knolle, U Naumann, R Bartenschlager, et al.
Digestion|March 8, 2000
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis CG Teuber, T Berg, R M Hoffmann, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxisU Naumann, U Protzer-Knolle, T Berg, et al.
Hepatology (Baltimore, Md.)|September 1, 1990
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosisA Stiehl, G Rudolph, R Raedsch, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction]R Zimmermann, V König, J Bauditz, et al.
Journal of Hepatology|October 9, 1998
A clinical and virological study of hepatitis C virus-related cryoglobulinemia in GermanyS M Weiner, T Berg, H Berthold, et al.
Journal of Medical Virology|August 10, 1999
Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donorsT Berg, E Schreier, H G Heuft, et al.
Transplantation Proceedings|September 2, 1998
Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantationK P Platz, A R Mueller, C Willimski, et al.
Transplantation|September 15, 1994
Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantationV König, U Hopf, P Neuhaus, et al.
Transplantation Proceedings|June 24, 1998
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantationK P Platz, A R Mueller, C Willimski, et al.
Hepatology (Baltimore, Md.)|January 13, 1998
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantationU Protzer-Knolle, U Naumann, R Bartenschlager, et al.
Digestion|March 8, 2000
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis CG Teuber, T Berg, R M Hoffmann, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxisU Naumann, U Protzer-Knolle, T Berg, et al.
Hepatology (Baltimore, Md.)|September 1, 1990
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosisA Stiehl, G Rudolph, R Raedsch, et al.
Pageof 18